Skip to main content

An official website of the United States government

You have 2 new alerts

Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE)

info alert

Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.

Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information

  • Contract Opportunity Type: Presolicitation (Updated)
  • Updated Published Date: Aug 16, 2024 10:07 am EDT
  • Original Published Date: Jul 31, 2024 09:57 am EDT
  • Updated Response Date: Oct 31, 2024 02:00 pm EDT
  • Original Response Date: Oct 31, 2024 02:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Updated Inactive Date: Nov 15, 2024
  • Original Inactive Date: Nov 15, 2024
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code: AN13 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
    Washington , DC
    USA

Description

August 16, 2024: The solicitation is updated to add the FAQ document.

The Advanced Research Projects Agency for Health (ARPA-H) is posting this DRAFT Innovative Solutions Opening (ISO) ARPA-H-SOL-24-111 for the Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE) Program in order to help potential proposers prepare for Proposer's Day and plan for solution summary submission. 

The finalized ISO and related attachments will be posted at a later date. 

Contact Information

Contracting Office Address

  • 1301 K Street NW Suite 1200 West
  • Washington , DC 20005
  • USA

Primary Point of Contact

Secondary Point of Contact





History